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Abstract
Background: There is little evidence on differences across health care systems in choice and
outcome of the treatment of chronic low back pain (CLBP) with spinal surgery and conservative
treatment as the main options. At least six randomised controlled trials comparing these two
options have been performed; they show conflicting results without clear-cut evidence for superior
effectiveness of any of the evaluated interventions and could not address whether treatment effect
varied across patient subgroups. Cost-utility analyses display inconsistent results when comparing
surgical and conservative treatment of CLBP. Due to its higher feasibility, we chose to conduct a
prospective observational cohort study.
Methods: This study aims to examine if
1. Differences across health care systems result in different treatment outcomes of surgical and
conservative treatment of CLBP
2. Patient characteristics (work-related, psychological factors, etc.) and co-interventions
(physiotherapy, cognitive behavioural therapy, return-to-work programs, etc.) modify the outcome
of treatment for CLBP
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treatment of CLBP.
This study will recruit 1000 patients from orthopaedic spine units, rehabilitation centres, and pain
clinics in Switzerland and New Zealand. Effectiveness will be measured by the Oswestry Disability
Index (ODI) at baseline and after six months. The change in ODI will be the primary endpoint of
this study.
Multiple linear regression models will be used, with the change in ODI from baseline to six months
as the dependent variable and the type of health care system, type of treatment, patient
characteristics, and co-interventions as independent variables. Interactions will be incorporated
between type of treatment and different co-interventions and patient characteristics. Cost-utility
will be measured with an index based on EQol-5D in combination with cost data.
Conclusion: This study will provide evidence if differences across health care systems in the
outcome of treatment of CLBP exist. It will classify patients with CLBP into different clinical
subgroups and help to identify specific target groups who might benefit from specific surgical or
conservative interventions. Furthermore, cost-utility differences will be identified for different
groups of patients with CLBP. Main results of this study should be replicated in future studies on
CLBP.
Background
Acute low back pain (ALBP) affects more than 70% of all
people at least once in their lifetime [1], and about 5%
develop nonspecific CLBP, which is defined as LBP lasting
longer than 12 weeks [2]. Although this is only a small
group of patients, the economic costs exceed those for the
treatment of ALBP by a significant amount [3].
Guidelines already exist for the management of CLBP [4],
but the main question in CLBP–whether to offer spinal
surgery or conservative treatment–is not clearly answered
[5].
With both intervention rates in spinal surgery and health
care consumers' expectations rising, critics are voicing
concern about a possible "overuse" of spinal surgery [6].
Conservative treatment of low back pain is an alternative
that might bridge the self-healing processes [7]. Some
authors see advantages for surgical procedures in terms of
cost-utility [8], whereas others see no significant differ-
ences between both treatment groups [9]. There is weak
evidence on differences across health care systems con-
cerning outcomes of CLBP that favours countries with a
National Health System (NHS) compared to countries
with a private health care system [10,11]. Evidence and
outcome-based research is needed to provide information
on the appropriate indication for spinal surgery [12]. The
aim would be to identify specific target groups that will
benefit from specific interventions and classify patients
with CLBP into different clinical subgroups [13].
At least six randomised trials have been performed com-
paring the outcomes of spinal surgery and nonsurgical
treatment in CLBP–most of them with some problems in
conduct.
Among these are the study by the Swedish lumbar spine
study group comparing patients with spinal surgery and
patients with continuing physical therapy [14]; the Nor-
wegian spine study comparing patients with lumbar
fusion plus physiotherapy, and patients with cognitive
intervention plus exercises [15]; the UK Medical Research
Council trial comparing patients with spinal stabilisation
and patients with an intensive rehabilitation programme
[16]; and the American Spine Patient Outcomes Research
Trial (SPORT) comparing patients with discectomy and
patients with physical therapy plus exercise therapy [17].
Further RCTs have been conducted for spondylolisthesis.
Some RCTs had to be closed because patients did not want
surgery.
These trials showed conflicting results, with no treatment
being clearly superior [18]. Exclusion criteria in all these
trials were restrictive; for example, patients with mild
CLBP and no need for surgery, as well as patients with pro-
gressive neurological abnormalities and surgery were
excluded. Recruitment in all trials was long and varied
between four and six years. This leads to a reduced gener-
alizability of the results.
The analysis of data from an observational cohort with
adequate statistical methods can lead to results with an
evidence level 2++. It is slowly recognized that for certain
clinical questions RCTs have limitations [19] and may be
unnecessary, inappropriate, or impossible to conduct
[20].Page 2 of 9
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lighted by the SPORT trial, which consists of a ran-
domised and an observational cohort. The rate of surgical
patients with treatment crossover within two years of
treatment allocation was 40% in the RCT, compared to
merely 4% in the observational cohort [17,21]. The com-
parable rates of conservative patients' crossover to surgery
were 45% and 22%. Currently, a prospective cohort study
comparing patients with lumbar fusion and patients with
multidisciplinary therapy is under way, for which a ran-
domised cohort design was planned, but was changed to
an observational design to minimise a treatment crosso-
ver [22].
Therefore, we chose to conduct a prospective observa-
tional cohort study as well, with a lower level of evidence
than an RCT though, but a higher feasibility.
Methods/design
Research plan
Objectives and goals
This study aims to identify differences across health care
systems in the Swiss and New Zealand populations such
as different compensation schemes, patient characteris-
tics, and co-interventions that modify the effects of surgi-
cal and conservative treatment of patients with CLBP. In
addition, differences in cost-utility will be identified for
different groups of patients.
Hypotheses
Three hypotheses will be examined:
1. Differences across health care systems result in better
treatment outcomes of surgical and conservative treat-
ment of CLBP in countries with a NHS.
2. Patient characteristics, such as high job satisfaction and
short pain duration, and co-interventions, such as cogni-
tive behavioural therapy and return-to-work programs,
increase the effectiveness of surgical and conservative
treatment for CLBP.
3. Cost-utility in terms of quality-adjusted life years
(QALYs) is higher in conservative than in surgical treat-
ment of CLBP.
Previous inconclusive findings may have resulted from
potential effect modifiers that varied across different
health care systems. For instance, expectations to return
quickly to work may function as an effect modifier
depending on the health compensation system. This study
will examine whether the results pertaining to hypotheses
2 and 3 vary by health care system.
Study design
In this multinational prospective cohort study, patients
will be recruited consecutively from orthopaedic spine
units, rehabilitation centres, and pain clinics in Switzer-
land (CH) and New Zealand (NZ). Participants will be
assessed pre-intervention and at six-month follow-up. The
duration of treatment will be a maximum of six months
per patient.
The study protocol has been approved by the Ethics Com-
mission of the Canton of Berne (KEK-Gesuchs-Nr.: 191/
07).
Inclusion and exclusion criteria
We defined broad inclusion criteria to ensure that the
spectrum of patients represents the spectrum seen in rou-
tine settings: CLBP with a duration of the current episode
of at least three months, no relevant improvement under
prior conservative treatment for one year, patients about
to undergo surgical or further conservative treatment, age
18–65 years at beginning of treatment, good understand-
ing of German in the Swiss patient sample or English the
New Zealand sample, and written consent (see table 1).
Exclusion criteria are specific CLBP (as infection, tumour,
osteoporosis, ankylosing spondylitis, fracture, deformity,
inflammatory process, and cauda equina syndrome),
acute or subacute LBP (defined as LBP continuing for less
than six respectively twelve weeks at beginning of treat-
ment [1,4], comorbidity that determines overall well-
being (e.g. painful/disabling arthritic hip joints), preg-
nancy, expected loss to follow-up (e.g. due to removal),
and unwillingness to complete questionnaires (see table
1).
Table 1: Inclusion and exclusion criteria
1. CLBP 7. specific CLBP
2. no relevant improvement under prior conservative treatment for one year 8. acute or subacute LBP
3. about to undergo surgical or further conservative treatment 9. comorbidity that determines overall well-being
4. age 18–65 years at the beginning of treatment 10. pregnancy
5. good understanding of German (CH) or English (NZ) 11. expected loss to follow-up
6. written consent 12. unwillingness to complete questionnairesPage 3 of 9
(page number not for citation purposes)
BMC Musculoskeletal Disorders 2008, 9:81 http://www.biomedcentral.com/1471-2474/9/81Interventions
Surgical treatment
Surgical interventions for CLBP in this study are fusion
(anterior and posterior lumbar interbody fusion, postero-
lateral instrumented fusion) and nonfusion surgery
(decompression, dynamic stabilization, total disc replace-
ment). Given the nature of interventions, a sham inter-
vention is not feasible.
Conservative treatment and co-interventions
We defined the absence of a surgical treatment as conserv-
ative treatment. Different conservative treatments are con-
sidered as co-interventions. These co-interventions that
also can be applied to the surgical patient group are bio-
medical, psychologically oriented (cognitive behavioural
therapy), and socio-occupational interventions (return-
to-work program). Biomedical interventions include
physical treatments, exercise therapy, manual therapy,
back schools, pharmacological procedures (analgetics,
NSAID, opioids, antidepressants), and invasive nonsurgi-
cal treatments (acupuncture, injections, facet/nerve root
blocks, neuroreflexotherapy, percutaneous electrical
nerve stimulation, radiofrequency, intradiscal electrother-
mal therapy, intradiscal radiofrequency thermocoagula-
tion, cryotherapy of the facets, alcohol denervation,
temporary epidural catheters, permanent intrathecal pain-
control pumps, and spinal cord stimulators).
Outcome assessment
Demographic and baseline characteristics
The following demographic and baseline characteristics
will be collected by patient self-assessment: gender, age,
comorbidity (SCQ), marital/relationship status, smoking
behaviour, onset/duration/recurrence of LBP, number/
level of previous spine surgeries, duration of previous con-
servative treatment, educational/work/disability compen-
sation status, work history, biomechanical workload,
duration of work-absenteeism, job satisfaction, work
stress factors, job control, social recognition of LBP from
supervisors and colleagues, pain tolerance during work,
belief that work has caused LBP, recovery/emotional dis-
tress after work, social stress factors, search for social sup-
port, condition-specific disability (ODI), general physical
and mental health (SF-36), cost-utility of treatment (index
based on EQol-5D in combination with cost data), inten-
sity of back and leg pain (VAS), pain frequency, location
and number of other painful body sites (SEQ pain assess-
ment), pain behaviour, pain control, self-efficacy, family
reinforcement of pain, interference of LBP with work and/
or activity, symptom-specific well-being, general well-
being, somatisation (MSPQ), depression (ZUNG), fear
avoidance beliefs (FABQ), coping strategies (CSQ), and
patients' expectations.
Physician-based assessment of patient characteristics at
baseline include centre/clinic of treatment, in/outpatient
treatment, height, weight, and medication.
Outcome measures
Relevant outcomes are identified as scores organised in
categories of answers in standardised multi-dimensional
assessment tools. Significance of outcomes is defined by
effect sizes (i.e. differences between treatment groups in
changes from baseline to endpoint, typically divided into
three groups: short-, medium-, and long-term changes of
respective scores). For this study, outcome measures will
be assessed at six-month follow-up. Longer follow-ups
may result in difficulties for the identification of effect
modifiers [23].
ODI [24,25], SF-36 [26], EQol-5D [27], and pain meas-
ured by VAS [28] are among the most frequently used out-
come assessment measurements of CLBP. All of them are
valid and reliable. In this study, the primary endpoint at
six-month follow-up is ODI. Key secondary endpoints are
SF-36, EQol-5D, and VAS.
Other secondary outcomes that will be collected by
patient self-assessment are onset/duration/recurrence of
LBP [29-31], work/disability compensation status
[32,33], duration of work-absenteeism [34], location and
number of other painful body sites [35,36], interference
of LBP with work and/or activity, symptom-specific well-
being, general well-being, and satisfaction with treatment.
Physician-based assessment of secondary treatment out-
comes at six-month follow-up include rate/type/therapeu-
tic consequences of complications [37], change in
medication, and overall outcome (McNab criteria).
Given the nature of interventions, blinding is not feasible.
Outcome assessments are based on standardised, reliable,
valid tools.
Effect modification
Possible effect modifiers are all co-interventions, as well
as all demographic and baseline characteristics [23,38-
40], which include gender [41], age [42], severity of pain
[43], comorbidity [44], socioeconomic status [45], work-
related factors [34,46,47], indirect reward parameters due
to the health care system [48], psychosocial distress [49-
52], somatisation and depression [53,54], fear-avoidance
beliefs and coping strategies [55,56], and expectations
[57].
Cost-utility
The socioeconomic objective of the study is to evaluate
the cost-utility outcomes of surgical and conservative
treatment of CLBP [8,9,27]. The costs considered includePage 4 of 9
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care system (insurance, public health care) and out-of-
pocket expenditures by patients (medication, alternative
medicine, personal prevention activities). The indirect
social costs due to lost productivity because of absentee-
ism also will be accounted for [58]. Direct medical costs
will collected from health insurance companies in CH, the
NHS in NZ and the clinics in which the patients are
selected. Indirect costs and out-of-pocket costs will be
measured with a cost diary developed by the Zurich Uni-
versity of Applied Sciences in cooperation with the MEM
Research Center. The cost diary will be kept by the patients
on a weekly basis covering the total period of treatment
with a maximum of six months. At beginning of treatment
and end of follow-up period utility will be measured with
an index based on EQol-5D and SF-36. Changes in the
index will be translated into changes in QALYs.
The cost study of CLBP patients will concentrate on the
segment of high-cost patients and address this question: Is
this group homogeneous with respect to their socioeco-
nomic status, care-seeking and back pain patterns? If the
answer is no, are there subgroups whose cost may be
reduced substantially by appropriate (nonmedical) sup-
port?
The cost-utility part of the study will be done in collabo-
ration with the Zurich University of Applied Sciences,
Institute of Health Economics.
Data management
Database
The backbone of this Swiss-based study is the IT-infra-
structure of the MEM Research Center, University of
Berne, which has developed and improved documenta-
tion systems and questionnaires over decades.
Orthopaedic spinal units, rehabilitation centres, and pain
clinics in CH and NZ will participate in this study. Collab-
orators in the main clinics will act as local coordinators in
association with local research nurses. The outcome
assessment is based on physician- and patient-derived
data.
After written informed consent patients will be examined
by the surgeons or physicians under whose care they are.
Research nurses will hand out self-assessment question-
naires to the patients and will be available to help com-
pleting these questionnaires if necessary. The completed
patient-based questionnaires will be collected by the
research nurses and, together with physician-based ques-
tionnaires, forwarded to the MEM Research Center in CH
respectively to the University of Otago in NZ. All data will
be saved at the central database of the main server at the
University of Berne.
Data security
The computerised medical data collected at the MEM
Research Center do not contain names. Only the patient
number will be able to connect the names and the medi-
cal information at the treatment level. The servers have
firewalls and data encryption, and are located in a physi-
cally secure environment.
Statistical Analysis
Outcomes
In this prospective cohort study, two interventions for
CLBP are compared: surgical and conservative treatment.
Subgroups of different surgical treatments can be distin-
guished. Nonsurgical co-interventions may have an effect
on patient groups with surgical as well as with conserva-
tive treatment.
Follow-up data at six months will be analysed according
to the intention-to-treat principle, except for those
patients who change treatment groups before the begin-
ning of the allocated treatment.
Changes in dependent outcome variables between base-
line and follow-up at six months will be analysed by mul-
tiple linear regression models. Surgical and conservative
treatment, patient characteristics, and co-interventions are
independent variables. To address potential effect modifi-
cation, we will then incorporate interactions between type
of treatment and the different co-interventions and
patient characteristics.
Highest priority among co-interventions will be given to
the analysis of effects of cognitive behavioural therapy
and return-to-work programs. Among patient characteris-
tics highest priority in data analysis will be given to gen-
der, age, and duration of work-absenteeism.
Costs
The most important cost predictors (including cost driv-
ers) for total, direct, and indirect costs are identified by
multivariate modelling approaches.
One multivariate modelling approach is to determine
which individuals with CLBP are in the top, say, 15% of
the total cost, and to contrast this group with the remain-
ing individuals. The relevant cost predictors are identified
by discriminant analysis, or any other suitable classifica-
tion method such as logistic classification or classification
trees.
Another approach is to model the costs by a multiple
regression type model, where the costs are assumed to be
log-Gaussian or gamma distributed. The uncertainty in
the prediction of cost will be quantified by state-of-the-art
methods [59,60].Page 5 of 9
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Sample size considerations in clinical studies start from
what is considered a minimal clinically important differ-
ence. In studies of chronic low back pain, the ODI is com-
monly used as the main outcome measure, and a
difference in 10 ODI points is considered clinically rele-
vant [61,62]. This study, however, aims at investigating
effect modification (by several candidate variables) of the
treatment effect of surgical versus conservative treatment.
This makes higher sample sizes necessary to have ade-
quate power to answer the question [63,64].
We considered a series of scenarios for sample size calcu-
lations. To simplify the scenarios, we assumed a 1:1 distri-
bution between patients undergoing surgical and
conservative treatment, and a 1:1 distribution for the can-
didate effect modifier variable (e.g., gender).
We then made assumptions about the standard deviation
of changes in ODI over a six-month period. From pub-
lished studies and unpublished data sets we calculated
scenarios with standard deviation ranging from 18 to 23
[14,16,21].
In general, an interaction effect of 0.4 to 0.6 of the main
treatment effect is considered relevant.
These assumptions resulted in an array of sample sizes
between 500 to 800 necessary to ensure 80% power to
assess the hypothesized levels of effect modifications.
Furthermore, we assumed a 20% rate of patients who will
not return on schedule to the six-month clinical visit at
which the main outcome measurements will be con-
ducted. These calculations showed that at least 800
patients should be included to provide 80% power to
detect this interaction effect at a two-sided p of 0.05 [63].
However, as there is uncertainty about the distribution of
effect modifiers, the proportion of patients opting for sur-
gery, and the proportion that will not be seen at six
months, we decided to set a target sample size of 1000
patients.
Feasibility of the study
The patient sample will be taken from orthopaedic spine
units, rehabilitation centres, and pain clinics in CH and
NZ. The feasibility of data collection in CH has been
proved in prior joint ventures between the MEM Research
Center and university and regional hospitals (e.g. Inselspi-
tal and Salem-Spital in Berne, Schulthess Clinic in Zurich,
all of them offering surgical and conservative treatment,
none of them working on a referral basis).
NZ has been chosen for comparison of differences across
health care systems because of ideal starting conditions
for this research project: NZ is a country with a tradition-
ally high acceptance of clinical research. For example, the
National Joint Register of patients who underwent total
hip or knee replacement, established in 1999, has near
100% coverage.
The MEM Research Center in Berne coordinates the Swiss-
based European Spine Registry of the Spine Society of
Europe (SSE) [65-70]. In parallel to the planned bi-
national multicentre study, a national spine registry for
NZ could be implemented by the University of Otago.
This National Spine Register – comparable to the existing
National Joint Register – would address all patients with
CLBP who report to a clinic in NZ, generating synergetic
effects. All patients joining the National Spine Register
could be asked to participate in the multicentre study as
well, which would make data collection much easier.
Cooperation on successful doctoral studies in both coun-
tries already exists between the University of Berne and
the University of Otago, NZ.
Furthermore, NZ has a manageable population size,
which is comparable to CH. This setting and the observa-
tional nature of the study will ensure sufficiently high
recruitment rates.
The respective acquisition of patient data will be coordi-
nated at the MEM Research Center and the University of
Otago. 2200 patients will be assessed for eligibility in CH
and NZ combined (see figure 1). It can be assumed that
75% of these screened patients will be found eligible for
enrolment. Out of these 1650 patients, presumably 990
(60%) will agree to participate in this study. Up to 20% of
the patients can be expected to be lost to follow-up in the
worst case scenario, so that, finally, 792 patients will be
analysed according to the intention-to-treat principle.
This estimate is based on data provided by a recent pro-
spective cohort study comparing surgical and conservative
treatment in a LBP population, with ODI as primary out-
come measures [21].
The expected duration of the entire study will be two and
a half years, including two years of patient recruitment
overlapping with two years of follow-up.
Discussion
Scientific significance
LBP is by far the most prevalent and most costly muscu-
loskeletal problem in advanced economic societies today.
Despite numerous previous studies, little is known about
differences across health care systems and its predictors,
and cost-utility analyses are rare. This study will provide
evidence if differences in the treatment of CLBP exist
across different health care systems. It will classify patientsPage 6 of 9
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identify specific target groups who will benefit from spe-
cific surgical or conservative interventions. These sub-
groups could be reassessed in future RCTs.
Findings from this study may lead to a paradigm shift in
the treatment of patients with CLBP and moreover, may
have an impact on future guidelines for the management
of CLBP.
Social and economic significance
We anticipate to identify cost-utility differences of treat-
ment choices for different groups of patients with CLBP
and to suggest areas with a high potential for improved
cost effectiveness. Both health care providers and consum-
ers might benefit if unnecessary spinal surgical procedures
can be avoided.
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